Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23237)

• Formulation Name: Natamycin 5% suspension
• Company: Eyevance

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Natamycin	(DMFEHXD)	Conjunctivitis	9A60	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Benzalkonium chloride	(E00536)	21988052	Antimicrobial preservative; Penetration agent; Solubilizing agent; Surfactant
Hydrochloric acid	(E00015)	313	Acidulant
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Water	(E00035)	962	Solvent